Contents

Current Pharmaceutical Design, Volume 19 - Number 22

Editorial (Hot Topic:Current Situation at Perioperative of Cardiovascular Disease Patients: New Addressing and Perioperative Optimization Techniques)

, 19(22): 3931

Jose Luis Guerrero Orriach


DOI: 10.2174/1381612811319220001




Clopidogrel, Aspirin and Proton Pump Inhibition after Percutaneous Valve Implants: An Update

, 19(22): 3932 - 3945

Melissa Fusari


DOI: 10.2174/1381612811319220002




Perioperative B-blockers in Non-cardiac Surgery: Actual Situation

, 19(22): 3946 - 3962

Ioanna Koniari and George Hahalis


DOI: 10.2174/1381612811319220003




Pharmacologic Treatment of Pulmonary Arterial Hypertension

, 19(22): 3963 - 3973

Gautam V. Ramani and Sartraj Gill


DOI: 10.2174/1381612811319220004




Levosimendan Preoperative

, 19(22): 3974 - 3978

Andrea Rognoni, Alessandro Lupi, Chiara Cavallino, Alessia Veia, Sara Bacchini, Roberta Rosso, Gioel Gabrio Secco and Angelo Sante Bongo


DOI: 10.2174/1381612811319220005




Corticosteroids for the Inflammatory Response to Cardiopulmonary Bypass: An Update

, 19(22): 3979 - 3991

Jan M. Dieleman


DOI: 10.2174/1381612811319220006




Pharmacologic Methods to Reduce Postoperative Bleeding in Adult Cardiac Surgery. A Mini-review

, 19(22): 3992 - 3995

Jan Jesper Andreasen


DOI: 10.2174/1381612811319220007




Sevoflurane in Intraoperative and Postoperative Cardiac Surgery Patients. Our Experience in Intensive Care Unit with Sevoflurane Sedation

, 19(22): 3996 - 4002

Jose Luis Guerrero Orriach, M. Ramirez Aliaga, Manuel Galan Ortega, Manuel Rubio Navarro, Isabel Navarro Arce and Jose Cruz Manas


DOI: 10.2174/1381612811319220008




Dexmedetomidine: A Review of its Use for the Management of Pain, Agitation, and Delirium in the Intensive Care Unit

, 19(22): 4003 - 4013

Kevin E. Anger


DOI: 10.2174/1381612811319220009




Safety and Efficacy of Bridging with Low Molecular Weight Heparins: A Systematic Review and Partial Meta-Analysis

, 19(22): 4014 - 4023

Pieter Eijgenraam, Hugo ten Cate and Arina ten Cate-Hoek


DOI: 10.2174/1381612811319220010




Editorial (The Ubiquitin Proteasome System as a Source of Drug Targets for Cancer Therapy)

, 19(22): 4024

Paola Perego


DOI: 10.2174/1381612811319220011




From Bortezomib to other Inhibitors of the Proteasome and Beyond

, 19(22): 4025 - 4038

Daniela Buac, Min Shen, Sara Schmitt, Fathima Rani Kona, Rahul Deshmukh, Zhen Zhang, Christine Neslund-Dudas, Bharati Mitra and Q. Ping Dou


DOI: 10.2174/1381612811319220012




Deubiquitinating Enzymes as Therapeutic Targets in Cancer

, 19(22): 4039 - 4052

Key-Hwan Lim and Kwang-Hyun Baek


DOI: 10.2174/1381612811319220013




Targeting the Ubiquitin Proteasome System: Beyond Proteasome Inhibition

, 19(22): 4053 - 4093

Wendy Xolalpa, Patricia Perez-Galan, Manuel S. Rodríguez and Gael Roue


DOI: 10.2174/1381612811319220014




Drug Combinations with Proteasome Inhibitors in Antitumor Therapy

, 19(22): 4094 - 4114

Laura Gatti, Valentina Zuco, Nadia Zaffaroni and Paola Perego


DOI: 10.2174/1381612811319220015




Non-Covalent Proteasome Inhibitors

, 19(22): 4115 - 4130

Julia Kaffy, Guillaume Bernadat and Sandrine Ongeri


DOI: 10.2174/1381612811319220016




Negative Regulation of NEDD8 Conjugation Pathway by Novel Molecules and Agents for Anticancer Therapy

, 19(22): 4131 - 4139

Tomoaki Tanaka, Tatsuya Nakatani and Tetsu Kamitani


DOI: 10.2174/1381612811319220017




Inhibitors of the Immunoproteasome: Current Status and Future Directions

, 19(22): 4140 - 4151

Zachary Miller, Lin Ao, Kyung Bo Kim and Wooin Lee


DOI: 10.2174/1381612811319220018




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science